메뉴 건너뛰기




Volumn 1803, Issue 3, 2010, Pages 386-395

Chk2 splice variants express a dominant-negative effect on the wild-type Chk2 kinase activity

Author keywords

Breast cancer; Chk2; Splicing

Indexed keywords

CHECKPOINT KINASE 2; MESSENGER RNA; NUCLEAR PROTEIN;

EID: 77249090660     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2010.01.005     Document Type: Article
Times cited : (24)

References (58)
  • 1
    • 0013394889 scopus 로고    scopus 로고
    • Mechanisms of alternative pre-messenger RNA splicing
    • Black D.L. Mechanisms of alternative pre-messenger RNA splicing. Annu. Rev. Biochem. 72 (2003) 291-336
    • (2003) Annu. Rev. Biochem. , vol.72 , pp. 291-336
    • Black, D.L.1
  • 2
    • 18344364099 scopus 로고    scopus 로고
    • Understanding alternative splicing: towards a cellular code
    • Matlin A.J., Clark F., and Smith C.W. Understanding alternative splicing: towards a cellular code. Nat. Rev., Mol. Cell Biol. 6 (2005) 386-398
    • (2005) Nat. Rev., Mol. Cell Biol. , vol.6 , pp. 386-398
    • Matlin, A.J.1    Clark, F.2    Smith, C.W.3
  • 3
    • 33746927884 scopus 로고    scopus 로고
    • The connection between splicing and cancer
    • Srebrow A., and Kornblihtt A.R. The connection between splicing and cancer. J. Cell Sci. 119 (2006) 2635-2641
    • (2006) J. Cell Sci. , vol.119 , pp. 2635-2641
    • Srebrow, A.1    Kornblihtt, A.R.2
  • 4
    • 0036534129 scopus 로고    scopus 로고
    • Alternative splicing: multiple control mechanisms and involvement in human disease
    • Caceres J.F., and Kornblihtt A.R. Alternative splicing: multiple control mechanisms and involvement in human disease. Trends Genet. 18 (2002) 186-193
    • (2002) Trends Genet. , vol.18 , pp. 186-193
    • Caceres, J.F.1    Kornblihtt, A.R.2
  • 5
    • 0037443035 scopus 로고    scopus 로고
    • Pre-mRNA splicing and human disease
    • Faustino N.A., and Cooper T.A. Pre-mRNA splicing and human disease. Genes Dev. 17 (2003) 419-437
    • (2003) Genes Dev. , vol.17 , pp. 419-437
    • Faustino, N.A.1    Cooper, T.A.2
  • 8
    • 7444220147 scopus 로고    scopus 로고
    • Aberrant and alternative splicing in cancer
    • Venables J.P. Aberrant and alternative splicing in cancer. Cancer Res. 64 (2004) 7647-7654
    • (2004) Cancer Res. , vol.64 , pp. 7647-7654
    • Venables, J.P.1
  • 10
    • 0034326802 scopus 로고    scopus 로고
    • Threonine 68 phosphorylation by ataxia telangiectasia mutated is required for efficient activation of Chk2 in response to ionizing radiation
    • Ahn J.Y., Schwarz J.K., Piwnica-Worms H., and Canman C.E. Threonine 68 phosphorylation by ataxia telangiectasia mutated is required for efficient activation of Chk2 in response to ionizing radiation. Cancer Res. 60 (2000) 5934-5936
    • (2000) Cancer Res. , vol.60 , pp. 5934-5936
    • Ahn, J.Y.1    Schwarz, J.K.2    Piwnica-Worms, H.3    Canman, C.E.4
  • 11
    • 0036258583 scopus 로고    scopus 로고
    • Chk2 activation and phosphorylation-dependent oligomerization
    • Xu X., Tsvetkov L.M., and Stern D.F. Chk2 activation and phosphorylation-dependent oligomerization. Mol. Cell. Biol. 22 (2002) 4419-4432
    • (2002) Mol. Cell. Biol. , vol.22 , pp. 4419-4432
    • Xu, X.1    Tsvetkov, L.M.2    Stern, D.F.3
  • 12
    • 0035839526 scopus 로고    scopus 로고
    • The hCds1 (Chk2)-FHA domain is essential for a chain of phosphorylation events on hCds1 that is induced by ionizing radiation
    • Lee C.H., and Chung J.H. The hCds1 (Chk2)-FHA domain is essential for a chain of phosphorylation events on hCds1 that is induced by ionizing radiation. J. Biol. Chem. 276 (2001) 30537-30541
    • (2001) J. Biol. Chem. , vol.276 , pp. 30537-30541
    • Lee, C.H.1    Chung, J.H.2
  • 13
    • 0037795780 scopus 로고    scopus 로고
    • Regulation of the Chk2 protein kinase by oligomerization-mediated cis- and trans-phosphorylation
    • Schwarz J.K., Lovly C.M., and Piwnica-Worms H. Regulation of the Chk2 protein kinase by oligomerization-mediated cis- and trans-phosphorylation. Mol. Cancer Res. 1 (2003) 598-609
    • (2003) Mol. Cancer Res. , vol.1 , pp. 598-609
    • Schwarz, J.K.1    Lovly, C.M.2    Piwnica-Worms, H.3
  • 14
    • 0035848819 scopus 로고    scopus 로고
    • The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis
    • Falck J., Mailand N., Syljuasen R.G., Bartek J., and Lukas J. The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis. Nature 410 (2001) 842-847
    • (2001) Nature , vol.410 , pp. 842-847
    • Falck, J.1    Mailand, N.2    Syljuasen, R.G.3    Bartek, J.4    Lukas, J.5
  • 16
    • 0032484084 scopus 로고    scopus 로고
    • Linkage of ATM to cell cycle regulation by the Chk2 protein kinase
    • Matsuoka S., Huang M., and Elledge S.J. Linkage of ATM to cell cycle regulation by the Chk2 protein kinase. Science 282 (1998) 1893-1897
    • (1998) Science , vol.282 , pp. 1893-1897
    • Matsuoka, S.1    Huang, M.2    Elledge, S.J.3
  • 17
    • 0034142034 scopus 로고    scopus 로고
    • The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites
    • Shieh S.Y., Ahn J., Tamai K., Taya Y., and Prives C. The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites. Genes Dev. 14 (2000) 289-300
    • (2000) Genes Dev. , vol.14 , pp. 289-300
    • Shieh, S.Y.1    Ahn, J.2    Tamai, K.3    Taya, Y.4    Prives, C.5
  • 19
    • 0034142325 scopus 로고    scopus 로고
    • Chk2/hCds1 functions as a DNA damage checkpoint in G(1) by stabilizing p53
    • Chehab N.H., Malikzay A., Appel M., and Halazonetis T.D. Chk2/hCds1 functions as a DNA damage checkpoint in G(1) by stabilizing p53. Genes Dev. 14 (2000) 278-288
    • (2000) Genes Dev. , vol.14 , pp. 278-288
    • Chehab, N.H.1    Malikzay, A.2    Appel, M.3    Halazonetis, T.D.4
  • 22
    • 0035866772 scopus 로고    scopus 로고
    • Influence of TP53 gene alterations and c-erbB-2 expression on the response to treatment with doxorubicin in locally advanced breast cancer
    • Geisler S., Lonning P.E., Aas T., Johnsen H., Fluge O., Haugen D.F., Lillehaug J.R., Akslen L.A., and Borresen-Dale A.L. Influence of TP53 gene alterations and c-erbB-2 expression on the response to treatment with doxorubicin in locally advanced breast cancer. Cancer Res. 61 (2001) 2505-2512
    • (2001) Cancer Res. , vol.61 , pp. 2505-2512
    • Geisler, S.1    Lonning, P.E.2    Aas, T.3    Johnsen, H.4    Fluge, O.5    Haugen, D.F.6    Lillehaug, J.R.7    Akslen, L.A.8    Borresen-Dale, A.L.9
  • 23
    • 0344198117 scopus 로고    scopus 로고
    • TP53 gene mutations predict the response to neoadjuvant treatment with 5-fluorouracil and mitomycin in locally advanced breast cancer
    • Geisler S., Borresen-Dale A.L., Johnsen H., Aas T., Geisler J., Akslen L.A., Anker G., and Lonning P.E. TP53 gene mutations predict the response to neoadjuvant treatment with 5-fluorouracil and mitomycin in locally advanced breast cancer. Clin. Cancer Res. 9 (2003) 5582-5588
    • (2003) Clin. Cancer Res. , vol.9 , pp. 5582-5588
    • Geisler, S.1    Borresen-Dale, A.L.2    Johnsen, H.3    Aas, T.4    Geisler, J.5    Akslen, L.A.6    Anker, G.7    Lonning, P.E.8
  • 24
    • 0038054343 scopus 로고    scopus 로고
    • The Chk2 tumor suppressor is not required for p53 responses in human cancer cells
    • Jallepalli P.V., Lengauer C., Vogelstein B., and Bunz F. The Chk2 tumor suppressor is not required for p53 responses in human cancer cells. J. Biol. Chem. 278 (2003) 20475-20479
    • (2003) J. Biol. Chem. , vol.278 , pp. 20475-20479
    • Jallepalli, P.V.1    Lengauer, C.2    Vogelstein, B.3    Bunz, F.4
  • 25
    • 15944413192 scopus 로고    scopus 로고
    • Identification and characterization of the human ARD1-NATH protein acetyltransferase complex
    • Arnesen T., Anderson D., Baldersheim C., Lanotte M., Varhaug J.E., and Lillehaug J.R. Identification and characterization of the human ARD1-NATH protein acetyltransferase complex. Biochem. J. 386 (2005) 433-443
    • (2005) Biochem. J. , vol.386 , pp. 433-443
    • Arnesen, T.1    Anderson, D.2    Baldersheim, C.3    Lanotte, M.4    Varhaug, J.E.5    Lillehaug, J.R.6
  • 26
    • 54049149934 scopus 로고    scopus 로고
    • Identification of the human N(alpha)-acetyltransferase complex B (hNatB): a complex important for cell-cycle progression
    • Starheim K.K., Arnesen T., Gromyko D., Ryningen A., Varhaug J.E., and Lillehaug J.R. Identification of the human N(alpha)-acetyltransferase complex B (hNatB): a complex important for cell-cycle progression. Biochem. J. 415 (2008) 325-331
    • (2008) Biochem. J. , vol.415 , pp. 325-331
    • Starheim, K.K.1    Arnesen, T.2    Gromyko, D.3    Ryningen, A.4    Varhaug, J.E.5    Lillehaug, J.R.6
  • 28
    • 0035817764 scopus 로고    scopus 로고
    • Functional impact of concomitant versus alternative defects in the Chk2-p53 tumour suppressor pathway
    • Falck J., Lukas C., Protopopova M., Lukas J., Selivanova G., and Bartek J. Functional impact of concomitant versus alternative defects in the Chk2-p53 tumour suppressor pathway. Oncogene 20 (2001) 5503-5510
    • (2001) Oncogene , vol.20 , pp. 5503-5510
    • Falck, J.1    Lukas, C.2    Protopopova, M.3    Lukas, J.4    Selivanova, G.5    Bartek, J.6
  • 30
    • 0141704306 scopus 로고    scopus 로고
    • Autophosphorylation of checkpoint kinase 2 at serine 516 is required for radiation-induced apoptosis
    • Wu X., and Chen J. Autophosphorylation of checkpoint kinase 2 at serine 516 is required for radiation-induced apoptosis. J. Biol. Chem. 278 (2003) 36163-36168
    • (2003) J. Biol. Chem. , vol.278 , pp. 36163-36168
    • Wu, X.1    Chen, J.2
  • 31
    • 0037205422 scopus 로고    scopus 로고
    • Phosphorylation of threonine 68 promotes oligomerization and autophosphorylation of the Chk2 protein kinase via the forkhead-associated domain
    • Ahn J.Y., Li X., Davis H.L., and Canman C.E. Phosphorylation of threonine 68 promotes oligomerization and autophosphorylation of the Chk2 protein kinase via the forkhead-associated domain. J. Biol. Chem. 277 (2002) 19389-19395
    • (2002) J. Biol. Chem. , vol.277 , pp. 19389-19395
    • Ahn, J.Y.1    Li, X.2    Davis, H.L.3    Canman, C.E.4
  • 35
    • 38349195014 scopus 로고    scopus 로고
    • Is CHEK2 a cause of the Li-Fraumeni syndrome?
    • Evans D.G., Birch J.M., and Narod S.A. Is CHEK2 a cause of the Li-Fraumeni syndrome?. J. Med. Genet. 45 (2008) 63-64
    • (2008) J. Med. Genet. , vol.45 , pp. 63-64
    • Evans, D.G.1    Birch, J.M.2    Narod, S.A.3
  • 36
    • 38349093562 scopus 로고    scopus 로고
    • BRCA2: a cause of Li-Fraumeni-like syndrome
    • Evans D.G., Wu C.L., and Birch J.M. BRCA2: a cause of Li-Fraumeni-like syndrome. J. Med. Genet. 45 (2008) 62-63
    • (2008) J. Med. Genet. , vol.45 , pp. 62-63
    • Evans, D.G.1    Wu, C.L.2    Birch, J.M.3
  • 38
  • 41
    • 33749039966 scopus 로고    scopus 로고
    • The CHEK2 gene and inherited breast cancer susceptibility
    • Nevanlinna H., and Bartek J. The CHEK2 gene and inherited breast cancer susceptibility. Oncogene 25 (2006) 5912-5919
    • (2006) Oncogene , vol.25 , pp. 5912-5919
    • Nevanlinna, H.1    Bartek, J.2
  • 42
    • 39149141409 scopus 로고    scopus 로고
    • CHEK2*1100delC genotyping for clinical assessment of breast cancer risk: meta-analyses of 26, 000 patient cases and 27, 000 controls
    • Weischer M., Bojesen S.E., Ellervik C., Tybjaerg-Hansen A., and Nordestgaard B.G. CHEK2*1100delC genotyping for clinical assessment of breast cancer risk: meta-analyses of 26, 000 patient cases and 27, 000 controls. J. Clin. Oncol. 26 (2008) 542-548
    • (2008) J. Clin. Oncol. , vol.26 , pp. 542-548
    • Weischer, M.1    Bojesen, S.E.2    Ellervik, C.3    Tybjaerg-Hansen, A.4    Nordestgaard, B.G.5
  • 50
    • 33845780616 scopus 로고    scopus 로고
    • Genetic and epigenetic analysis of CHEK2 in sporadic breast, colon, and ovarian cancers
    • Williams L.H., Choong D., Johnson S.A., and Campbell I.G. Genetic and epigenetic analysis of CHEK2 in sporadic breast, colon, and ovarian cancers. Clin. Cancer Res. 12 (2006) 6967-6972
    • (2006) Clin. Cancer Res. , vol.12 , pp. 6967-6972
    • Williams, L.H.1    Choong, D.2    Johnson, S.A.3    Campbell, I.G.4
  • 51
    • 34249803226 scopus 로고    scopus 로고
    • LEDGF/p75 has increased expression in blasts from chemotherapy-resistant human acute myelogenic leukemia patients and protects leukemia cells from apoptosis in vitro
    • Huang T.S., Myklebust L.M., Kjarland E., Gjertsen B.T., Pendino F., Bruserud O., Doskeland S.O., and Lillehaug J.R. LEDGF/p75 has increased expression in blasts from chemotherapy-resistant human acute myelogenic leukemia patients and protects leukemia cells from apoptosis in vitro. Mol. Cancer 6 (2007) 31
    • (2007) Mol. Cancer , vol.6 , pp. 31
    • Huang, T.S.1    Myklebust, L.M.2    Kjarland, E.3    Gjertsen, B.T.4    Pendino, F.5    Bruserud, O.6    Doskeland, S.O.7    Lillehaug, J.R.8
  • 52
    • 19344374275 scopus 로고    scopus 로고
    • RIP3 beta and RIP3 gamma, two novel splice variants of receptor-interacting protein 3 (RIP3), downregulate RIP3-induced apoptosis
    • Yang Y., Hu W., Feng S., Ma J., and Wu M. RIP3 beta and RIP3 gamma, two novel splice variants of receptor-interacting protein 3 (RIP3), downregulate RIP3-induced apoptosis. Biochem. Biophys. Res. Commun. 332 (2005) 181-187
    • (2005) Biochem. Biophys. Res. Commun. , vol.332 , pp. 181-187
    • Yang, Y.1    Hu, W.2    Feng, S.3    Ma, J.4    Wu, M.5
  • 55
    • 0037073737 scopus 로고    scopus 로고
    • Checkpoint kinase 2 (Chk2) monomers or dimers phosphorylate Cdc25C after DNA damage regardless of threonine 68 phosphorylation
    • Ahn J., and Prives C. Checkpoint kinase 2 (Chk2) monomers or dimers phosphorylate Cdc25C after DNA damage regardless of threonine 68 phosphorylation. J. Biol. Chem. 277 (2002) 48418-48426
    • (2002) J. Biol. Chem. , vol.277 , pp. 48418-48426
    • Ahn, J.1    Prives, C.2
  • 58
    • 0038418869 scopus 로고    scopus 로고
    • Chk1 and Chk2 kinases in checkpoint control and cancer
    • Bartek J., and Lukas J. Chk1 and Chk2 kinases in checkpoint control and cancer. Cancer Cells 3 (2003) 421-429
    • (2003) Cancer Cells , vol.3 , pp. 421-429
    • Bartek, J.1    Lukas, J.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.